ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
EQRx signs $1.8bn merger deal with CM Life Sciences III pharmaceutical-technology
August 10, 2021Pharmaceutical company EQRx and a life science-focused special purpose acquisition company (SPAC), CM Life Sciences III, have signed a definitive business combination agreement worth up to $1.8bn.
Pharma Sources Insight January 2025
